Acuvi AB (STO:ACUVI)
Sweden · Delayed Price · Currency is SEK 11.34
-0.66 (-5.50%)
At close: May 4, 2026
Acuvi AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 204.35 | 204.16 | 175.85 | 190.82 | 188.98 | 51.44 |
Other Revenue | 2.44 | 3.15 | 6.02 | 9.97 | - | - |
| 206.79 | 207.31 | 181.88 | 200.79 | 188.98 | 51.44 | |
Revenue Growth (YoY) | 9.51% | 13.98% | -9.42% | 6.25% | 267.38% | 87.86% |
Cost of Revenue | 82.18 | 78.38 | 63.8 | 79.23 | 97.88 | 60.93 |
Gross Profit | 124.61 | 128.93 | 118.08 | 121.55 | 91.1 | -9.49 |
Selling, General & Admin | 102.82 | 97.9 | 88.19 | 87.1 | 108.53 | 24.82 |
Research & Development | - | - | - | - | - | 14.54 |
Amortization of Goodwill & Intangibles | 23.81 | 16.83 | 3.07 | 12.04 | 94.13 | - |
Other Operating Expenses | 8.61 | 10.73 | -1.96 | -4.79 | 1.09 | -1.93 |
Operating Expenses | 144.44 | 134.5 | 98.11 | 103.48 | 206.97 | 37.43 |
Operating Income | -19.82 | -5.58 | 19.97 | 18.07 | -115.87 | -46.92 |
Interest Expense | -5.19 | -6.89 | -7.04 | -13.87 | -2.28 | - |
Interest & Investment Income | 0.34 | 0.08 | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | 14.52 | 0.22 | 25.64 | - |
Other Non Operating Income (Expenses) | - | - | - | 0 | -0.39 | -0.19 |
EBT Excluding Unusual Items | -24.67 | -12.39 | 27.46 | 4.42 | -92.9 | -47.11 |
Merger & Restructuring Charges | - | - | - | - | -11.73 | - |
Gain (Loss) on Sale of Assets | - | - | -0.16 | - | - | - |
Pretax Income | -24.67 | -12.39 | 27.3 | 4.42 | -104.64 | -47.11 |
Income Tax Expense | 3.22 | 2.96 | -1.37 | -2.08 | -8.22 | 0.75 |
Net Income | -27.89 | -15.35 | 28.67 | 6.5 | -96.42 | -47.86 |
Net Income to Common | -27.89 | -15.35 | 28.67 | 6.5 | -96.42 | -47.86 |
Net Income Growth | - | - | 341.15% | - | - | - |
Shares Outstanding (Basic) | 33 | 32 | 28 | 26 | 25 | 18 |
Shares Outstanding (Diluted) | 33 | 33 | 28 | 26 | 25 | 18 |
Shares Change (YoY) | 16.46% | 18.48% | 7.73% | 2.88% | 34.66% | 22.60% |
EPS (Basic) | -0.83 | -0.47 | 1.04 | 0.25 | -3.88 | -2.59 |
EPS (Diluted) | -0.83 | -0.47 | 1.04 | 0.25 | -3.88 | -2.59 |
EPS Growth | - | - | 316.00% | - | - | - |
Free Cash Flow | 1.31 | -2.86 | -1.8 | 22.98 | -18.96 | -24.92 |
Free Cash Flow Per Share | 0.04 | -0.09 | -0.07 | 0.90 | -0.76 | -1.35 |
Gross Margin | 60.26% | 62.19% | 64.92% | 60.54% | 48.21% | -18.44% |
Operating Margin | -9.59% | -2.69% | 10.98% | 9.00% | -61.31% | -91.20% |
Profit Margin | -13.49% | -7.40% | 15.76% | 3.24% | -51.02% | -93.03% |
Free Cash Flow Margin | 0.63% | -1.38% | -0.99% | 11.45% | -10.03% | -48.45% |
EBITDA | 13.19 | 20.3 | 23.9 | 29.06 | -21.26 | -29.96 |
EBITDA Margin | 6.38% | 9.79% | 13.14% | 14.47% | -11.25% | -58.24% |
D&A For EBITDA | 33.01 | 25.88 | 3.93 | 10.99 | 94.61 | 16.96 |
EBIT | -19.82 | -5.58 | 19.97 | 18.07 | -115.87 | -46.92 |
EBIT Margin | -9.59% | -2.69% | 10.98% | 9.00% | -61.31% | -91.20% |
Revenue as Reported | 207.31 | 207.31 | 183.91 | 209.64 | 192.44 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.